Literature DB >> 26649664

New data on the safety of IV iron-but why the discrepancy with FIND-CKD?

Iain C Macdougall1, Simon D Roger2.   

Abstract

Entities:  

Year:  2015        PMID： 26649664     DOI： 10.1038/ki.2015.302

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  1 in total

1.  FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia.

Authors:  Iain C Macdougall; Andreas H Bock; Fernando Carrera; Kai-Uwe Eckardt; Carlo Gaillard; David Van Wyck; Bernard Roubert; Jacqueline G Nolen; Simon D Roger
Journal:  Nephrol Dial Transplant       Date:  2014-06-02       Impact factor: 5.992
  1 in total
  5 in total

Review 1.  Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease.

Authors:  Simon D Roger
Journal:  Clin Kidney J       Date:  2017-11-28

Review 2.  Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions.

Authors:  Iain C Macdougall
Journal:  Clin Kidney J       Date:  2017-11-28

3.  The Author Replies.

Authors:  Rajiv Agarwal
Journal:  Kidney Int       Date:  2015-12       Impact factor: 10.612

4.  Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.

Authors:  Sunil Bhandari; Philip A Kalra; Mario Berkowitz; Diogo Belo; Lars L Thomsen; Myles Wolf
Journal:  Nephrol Dial Transplant       Date:  2021-01-01       Impact factor: 5.992

Review 5.  Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency.

Authors:  Iain C Macdougall; Josep Comin-Colet; Christian Breymann; Donat R Spahn; Ioannis E Koutroubakis
Journal:  Adv Ther       Date:  2020-04-15       Impact factor: 3.845
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.